BioSpace News Archive

Business

Valens expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets

Valens expands exclusive licence for SōRSE cannabis emulsion technology to include Europe, Australia and Mexico in addition to Canada

December 11, 2019
·
9 min read
Lone Star Bio

NantHealth Presents Research Demonstrating Real World Evidence of Simultaneous Presentation and Publication of Oncology Data at the 2019 San Antonio Breast Cancer Symposium

Eviti Connect study showed an increase in clinical uptake of practice-changing data

December 11, 2019
·
5 min read
BioCapital

CytoDyn to Hold Investment Community Conference Call on December 17, 2019

A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 30 days.

December 11, 2019
·
1 min read
Drug Development

Helix BioPharma Corp. Commences L-DOS47 Phase lb/ll Pancreatic Cancer Clinical Study

The study is entitled “A Phase Ib/II Study of the Microenvironment Modifier L-DOS47 plus Doxorubicin for the Treatment of Patients with Previously Treated Advanced Pancreatic Cancer”.

December 11, 2019
·
4 min read
Deals

Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.

EONE-Diagnomics was one of the most successful biotech IPOs (2018) on the KOSDAQ exchange.

December 11, 2019
·
4 min read
Business

New diagnostic methods to monitor blood disorders enabled by bio-rad’s droplet digital PCR technology showcased at 2019 Ash Annual Meeting

The research presented will illustrate the sensitivity, precision, and speed of Bio-Rad’s ddPCR, which enables researchers and clinicians to monitor biomarkers of malignant and nonmalignant blood disorders cost-effectively and at scale.

December 11, 2019
·
6 min read
Pharm Country

Therapeer Launches Peer-Led Mobile App

A Virtual Place To Give And Receive Real-Time Emotional Support

December 11, 2019
·
2 min read
Business

Why Pharmaceutical R&D Global Spending Could Exceed $200 Billion by 2024

According to various industry and market publications, pharmaceutical companies spend, on average, 17% of revenues on R&D, making it one of the biggest spenders in this area.

December 11, 2019
·
11 min read
BioCapital

Hememics Biotechnologies Inc. Received $2.5 Million Investment from AMVI Partners

Hememics Biotechnologies Inc., (“Hememics” or the “Company”) announced that AMVI Partners, a consortium of high net worth Vietnamese investors, has invested $2.5 million into Hememics.

December 11, 2019
·
2 min read
BioCapital

FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug

The U.S. Food and Drug Administration today posted a warning letter to Alkermes, Inc. of Massachusetts, for misbranding the drug Vivitrol (an extended-release injection formulation of naltrexone) by omitting warnings about the most serious risks associated with the drug from promotional materials

December 11, 2019
·
4 min read